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This study aimed to evaluate the effects of ursolic acid, hyperinsulinemia and 
vitamin B complex on sciatic nerve repair in diabetes mellitus male rabbits, 
determination of their effects on lipid profile and histological structures of the sciatic 
nerve. The results of  our study showed that alloxan induced diabetes caused a 
significant increase (p<0.05)   in serum cholesterol and triglyceride while treatment of 
extracted and standard ursolic acid, hyperinsulinemia and vitamin B complex caused a 
significant decrease (p<0.05) in serum cholesterol and triglyceride. There are 
significantly decreased (p<0.05) in serum high density lipoprotein (HDL) and 
significantly increase (p<0.05) in serum low density lipoprotein (LDL) is found in 
induced diabetic and hyperinsulinemia groups while there is a significant increase 
(p<0.05) of HDL in all treated groups except hyperinsulinemic group, on the other 
hand, there is a significant decrease (p<0.05) in LDL, especially in extracting ursolic 
acid group (p<0.05). Histological sections of sciatic nerve confirmed there is a 
degeneration of nerve fibers appears as areas of cloudy swelling and fatty de- 
generation of the nerve fibers due to nerve crush. There are various improvement changes 
due to the different treatment type. 
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Diabetes Mellitus (DM) is metabolic variation categorized by the incidence of chronic 
hyperglycemia accompanied in a different degree, by alterations in the metabolism of 
protein, lipids and carbohydrate [1] as an effect of disorder on insulin secretion, insulin 
activity or both. The diabetes type depends on the suppose etiology. It consists of two 
types of diabetes mellitus widely prevalent that are diabetes mellitus type1 and type 2 [2]. 
The traditional signs of diabetes are polyuria, polydipsia, and polyphagia [3]  
 
Ursolic acid (UA) (3β-hydroxyurs-12-en-28-oic acid) is a pentacyclic triterpenoid that 
exists in various plants and is a component of numerous herbal medicines [4]. It is the 
major effective component among the other triterpenoids in ap-  ple peels [5]. Ursolic 
acid has antibacterial, antifungal, insecticidal, anti-HIV, complement inhibitor, diuretic, 
antidiabetogenic and gastrointestinal system ad- justing actions [6] [7]. It has antitumor 
action [8], and produces anti-inflammatory influence in cells with definite 
inflammation, but in normal cells, it can be pro-inflammatory [9]. 
 
Hyperinsulinemia is a situation with a level of blood insulin greater than normal level 
in individuals without diabetes. Although hyperinsulinemia is not diabetes, it is usually 
accompanied with diabetes type2. [10] [11]  
 
The sciatic nerve, innervating the hind limb; it involves mixed of motor and sensory 
axons and is usually used as a model for studying regeneration of the nerve and its regener- 
ation is associated with a variety of changes in the dorsal root ganglion (DRG) neuron cell 










2 -Materials  and Methods 
3 -Animals 
Fifty healthy-mature male local rabbits (Lepus cuniculus) obtained from the local 
market- places of Basrah, their weights ranged from (900 g – 1.900 g) and ages between 
5–8 months were adapted for one week in an animal house of the College of Veterinary 
Medicine/ Basrah University. The experimental period lasts for seven weeks included 
(one week – adaptation period, three weeks – DM induction, one week – sciatic nerve 
crush surgery and two week treatment period). The animals were distributed into five 
groups (ten animals in each group). Diabetes Mellitus was induced in all groups by 200 
mg/ kg intravenous injection of Alloxan [13]; each group divided into two subgroups 
without and with sciatic nerve crush operation by an incision made over the lateral 
aspect of the hind limb.  The sciatic nerve of the left limb was crushed   at the mid-thigh 
level using a small hemostatic forceps for a period of 60 Second [14]; then each group 
except (G1+ve control/ diabetic rabbits) treated with different treatment for two weeks, 
the treatments include extracted ursolic acid (50 mg/ kg) [15], standard ursolic acid (50 
mg/ kg) [15], hyperinsulinemia (1.2 IU/ kg Insulin) [16] and Vitamin B complex (2 mg/ 
kg) [17], respectively. 
 
4 -Lipid  Profile Measurements: 
4.1 -Determination of Serum Cholesterol 
Serum Cholesterol level in the blood was measured by the enzymatic method of a 
com- mercial kit (BioMerieux; France) using the enzymatic method of [18]  
 
4.1.1 - Determination of Serum Triglyceride 
Serum triglyceride was measured by (BioMerieux; France) Kit depending on the 
enzy- matic method of [19]. 
 
Determination of Serum HDL and LDL The measurement was done by the 
(BioMerieux; France) Kit depending on the enzymatic method of [20] . 
 
5 -Histological parameter 
The sciatic nerve was isolated and fixed in 10% formalin. The fixed tissues were pro- 
cessed routinely for paraffin embedding; the sections were deparaffinized using xylene 
and dehydrated in a gradient of alcohol solutions. The Sciatic nerve sections were stained 
with Hematoxylin and Eosin stain as a routine histological stain used to demonstrate the 
general composition of the tissue [21]. 
  
 





6 -Statistical Analysis 
All data were expressed as means±SD. Significant differences among the 
experimental groups were determined by one way ANOVA method analysis of 
variance. Statistical significance was considered significant at p<0.05 [22].  
 
7 -Results 
8 -Lipid  Profile Measurements 
The Lipid Profile Measurements for serum cholesterol, triglyceride, HDL and LDL 








Means bear different letters differs significantly at the 5 % level. 
The statistical analysis of our study shows significantly (p<0.05) increases serum 
cholesterol and triglycerides of both crushed and non-crushed sciatic nerve. It is also 
clear from the table that treatment with Ursolic Acid either extracted or standard shows 
significantly decrease these two parameters more than diabetic group despite the crush in- 
jury. Hyperinsulinemia significantly decreases cholesterol of crushed injury sciatic nerve 
rabbits, but increases non-crushed rabbits cholesterol; the result of triglycerides for hy- 
perinsulinemia is vice versa. Vitamin B complex treatment significantly decreases serum 
cholesterol of both crushed and non-crushed diabetic rabbits. But it significantly de- 
creased triglycerides of only non-crushed sciatic nerve diabetic male rabbits. 
 






It is clear from the table that in induced diabetes group there is significantly decreased 
(p<0.05) serum HDL and significantly increase (p<0.05) serum LDL. It is also clear from 
the table that all treatment groups cause such increase in HDL accept hyperinsulinemia 
which causes a significant decrease in HDL (p<0.05). In the case of serum LDL treat- 
ment with extracted ursolic acid cause a significant decrease in LDL. Standard ursolic 
acid caused a significant increase (p<0.05) in this parameter. Hyperinsulinemia treatment 
caused a highly significant increase in LDL in non-crushed sciatic nerve diabetic rabbits 
but causes a significant decrease (p<0.05) in crushed sciatic nerve diabetic rabbits while 
treatment with Vitamin B complex causes a significant increase (p<0.05) in LDL. 
 






















Lipid Profile Measurements were investigated in our study in order to examine the 
effect of diabetes and different treatments to the rabbit’s serum cholesterol, triglyceride, 
HDL and LDL. 
 
The outcome of serum lipid profile laboratory investigations done on the studied rab- 
bits demonstrated in the tables (1 and 2).  It is clear that there is a significant eleva-   
tion (p<0.05) of serum cholesterol of alloxan induced rabbits and highly significant, rise 
(p<0.05) of triglyceride (TG). While there is a more significant decrease (p<0.05) of high- 
density lipoprotein (HDL) in alloxan induced diabetic rabbits. In addition, there is a sig- 
nificant increase (p<0.05) of low-density lipoprotein (LDL) of diabetic rabbits. 
 
All these measurement results resemble those found by [23] on al- loxan induced 
diabetic rabbits.  These findings also are comparable with that reported by [24] [25] [26] 
[27] . 
 
The reason for these findings is that in normal conditions there is suppression of the 
release of free fatty acids into the circulation due to inhibition of lipolysis because of the 
active effect of insulin which inhibits the lipase enzyme activity that is responsible for the 
lipolysis process [28]. 
 
In diabetes mellitus, there is insufficient insulin leads to the activation of lipase en- 
zyme and enhancement of lipolysis and subsequently discharges more free fatty acids 
into the blood circulation [29]. Moreover, the presence of extra fatty acids in plasma due 
to alloxan induced hyperglycemia enhances liver to convert some of them into 












Results in the table (1) showed a significant reduction (p<0.05) of cholesterol and 
triglyceride when treated with ursolic acid are coming to an agreement with results found 
by [31] when found that ursolic acid decrease the level of triacyl glyc- erol in the 
plasma via the inhibition of pancreatic lipase and by stimulating lipolysis in adipocytes. 
Furthermore, [32] found the same result that this study found when the stated that 
Ursolic Acid has the ability to reduce the level of plasma total cholesterol, free fatty 
acids and triglycerides in diabetic mice. 
 
It is obvious from the table that hyperinsulinemia causes a significant increase 
(p<0.05) in the cholesterol and triglyceride levels if compared with other treatment 
groups as well as with the diabetic group (positive). These results are assisted by those 
found by [33] and [34] when stated that insulin resis- tance is commonly associated with 
hyperinsulinemia and hypertriglyceridemia, also [35] found that it is associated with an 
increase in LDL-TG production. Because of the close correlation between TG 
production rate and hyperinsulinemia, it has generally been assumed that insulin 
facilitates LDL production, particularly when plasma free fatty acids and glucose levels 
are elevated [36].  It  is also clear from the table (1 and 2) that treatment with Vitamin B 
complex decreases serum cholesterol and triglyceride of non-crushed sciatic nerve 
diabetic rabbits, but it significantly increases HDL and little effect on LDL. 
 
Different degrees of histological changes in the sciatic nerve after examination of 
several histological slides from all the experimental groups which clearly appeared in 
(Figures 1-6) stained with Hematoxylin Eosin stain. After crush injury of alloxan in- 
duced diabetes rabbits and after treatments that are used in this study, several histological 
changes were found in those slides as shown in the figures mentioned; those changes 
could be noticed four days after crush injury and after two weeks after the treatments as 
mentioned by several workers such as [37] and [38]. These changes included 
degeneration of axons when started as a cloudy swelling and fatty degenerations 
followed by myelin sheath destruction and the prolifera- tion of a larger number of 
Schwann cells, all such changes are found in slides taken from the groups of our 
experiment and also mentioned by the above-mentioned workers. 
 
To encourage the phenomenon of healing, regeneration, and recovery of damaged 
nerve by crush injured many drugs have been used, these drugs can help in nerve 
regeneration or healing or pain relief.  Such drugs involve  systemic steroid or local  
ones [39] [40] [41]. But in our study, we used ursolic acid extracted from green apple 
peels compared with standard imported one as well as using insulin and vitamin B 
complex. The results we obtained are very good results of healing using extracted ursolic 
acid compared to insulin. Vitamin B complex gave very good results which are 
documented by the results found by and [42]. When concluded that vitamins B was 
considered as the best drugs which can be used in the regeneration of damaged nerves. 
[43] and [44] stated that the vitamin B complex has shown to promote regeneration and 
functional recovery of injured sciatic nerve and regeneration of nerve fibers with their 









Very good results of sciatic nerve regeneration obtained by using Ursolic Acid in 
this study are agreeing with what is found by [45] when they stated that Ursolic Acid 
can promote repair of peripheral nerves, can repair damaged neurons and promote neural 
regeneration after peripheral nerve injury. 
 
11 -Conclusions 
From the results of this experiment, we can conclude that Alloxan induced diabetes 
causes degeneration of the peripheral nerve represented by the sciatic nerve. Treatment 
with ur- solic acid that extracted from apple peels can overcome degenerative processes 
in the sciatic nerve and has positive effects on lipid profile measurement. Physiologic 
hyper- insulinemia has less effect on studying parameters compared to ursolic acid. 
Treatment with vitamin B complex gave positive results and can overcome bad results 
which occur due to diabetes and crush injury to the sciatic nerve. 
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